 The majority of CFTR in the lung's passages is produced by rare ion-transporting cells that regulate mucus properties.In addition, the evidence is increasing that genetic modifiers besides "CFTR" modulate the frequency and severity of the disease.One example is mannan-binding lectin, which is involved in innate immunity by facilitating phagocytosis of microorganisms.